-
Je něco špatně v tomto záznamu ?
Two panels of steroid receptor luciferase reporter cell lines for compound profiling
D. Sedlák, A. Paguio, P. Bartůněk,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- aktivace transkripce účinky léků MeSH
- genetické inženýrství metody MeSH
- knihovny malých molekul analýza MeSH
- lidé MeSH
- luciferasy genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- objevování léků metody MeSH
- plazmidy genetika MeSH
- promotorové oblasti (genetika) účinky léků MeSH
- rekombinantní proteiny genetika metabolismus MeSH
- reportérové geny MeSH
- rychlé screeningové testy metody MeSH
- sekvenční delece MeSH
- steroidní receptory agonisté antagonisté a inhibitory genetika metabolismus MeSH
- steroidy farmakologie MeSH
- transfekce MeSH
- transkripční faktory genetika metabolismus MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027762
- 003
- CZ-PrNML
- 005
- 20130118102720.0
- 007
- ta
- 008
- 120817s2011 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/138620711795222446 $2 doi
- 035 __
- $a (PubMed)21375502
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Sedlák, David $u Center for Chemical Genetics, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Vídeňská, Prague, Czech Republic. bartunek@img.cas.cz
- 245 10
- $a Two panels of steroid receptor luciferase reporter cell lines for compound profiling / $c D. Sedlák, A. Paguio, P. Bartůněk,
- 520 9_
- $a Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a objevování léků $x metody $7 D055808
- 650 _2
- $a reportérové geny $7 D017930
- 650 _2
- $a genetické inženýrství $x metody $7 D005818
- 650 _2
- $a rychlé screeningové testy $x metody $7 D057166
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a luciferasy $x genetika $x metabolismus $7 D008156
- 650 _2
- $a plazmidy $x genetika $7 D010957
- 650 _2
- $a promotorové oblasti (genetika) $x účinky léků $7 D011401
- 650 _2
- $a steroidní receptory $x agonisté $x antagonisté a inhibitory $x genetika $x metabolismus $7 D011987
- 650 _2
- $a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
- 650 _2
- $a sekvenční delece $7 D017384
- 650 _2
- $a knihovny malých molekul $x analýza $7 D054852
- 650 _2
- $a steroidy $x farmakologie $7 D013256
- 650 _2
- $a transkripční faktory $x genetika $x metabolismus $7 D014157
- 650 _2
- $a aktivace transkripce $x účinky léků $7 D015533
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Paguio, Aileen
- 700 1_
- $a Bartůněk, Petr
- 773 0_
- $w MED00180203 $t Combinatorial chemistry & high throughput screening $x 1875-5402 $g Roč. 14, č. 4 (2011), s. 248-66
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21375502 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130118102834 $b ABA008
- 999 __
- $a ok $b bmc $g 949804 $s 785108
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 14 $c 4 $d 248-66 $i 1875-5402 $m Combinatorial chemistry & high throughput screening $n Comb Chem High Throughput Screen $x MED00180203
- LZP __
- $a Pubmed-20120817/11/03